ZMYM6NB Inhibitors
Chemical inhibitors of ZMYM6NB function by modulating the acetylation status of histones, a key factor in the chromatin binding ability and transcriptional regulation activities of the protein. Histone deacetylase inhibitors (HDACi) such as Trichostatin A, Vorinostat, Panobinostat, Entinostat, Romidepsin, Belinostat, Quisinostat, Tacedinaline, Givinostat, Chidamide, Valproic acid, and Mocetinostat operate by obstructing the enzymatic activity that removes acetyl groups from histone tails. By doing so, these inhibitors induce hyperacetylation of histones, which can lead to a more open and transcriptionally active chromatin structure. This state of hyperacetylation can prevent ZMYM6NB from effectively binding to its target sites on chromatin, thereby inhibiting its normal role in transcriptional repression.
Among these inhibitors, Trichostatin A, Vorinostat, and Romidepsin are known for their broad-spectrum activity against histone deacetylases, while others like Entinostat and Mocetinostat exhibit more selective inhibition profiles. Regardless of their selectivity, the principal action remains the same; they elevate the acetylation levels of histones. This alteration in the chromatin landscape can interrupt the functional interaction between ZMYM6NB and chromatin, leading to a disruption of its role in chromatin remodeling and gene expression regulation. The effects of acetylation are not limited to histone proteins; therefore, these inhibitors can also modify the acetylation status of ZMYM6NB itself, potentially further impairing its ability to interact with other chromatin-associated proteins and its overall regulatory functions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that can potentially lead to the hyperacetylation of ZMYM6NB, thereby altering its chromatin binding ability, which could inhibit its function in transcriptional repression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat, like Trichostatin A, inhibits histone deacetylases. By increasing acetylation levels, it may impair ZMYM6NB's ability to interact with deacetylated histones, potentially inhibiting its role in chromatin remodeling and gene silencing. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Panobinostat is a potent histone deacetylase inhibitor, which can affect the acetylation status of histones, possibly disrupting ZMYM6NB's interaction with chromatin, leading to functional inhibition of its gene regulatory activities. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Entinostat selectively inhibits class I histone deacetylases. This specificity might disrupt ZMYM6NB's interaction with chromatin by maintaining a hyperacetylated state, thereby inhibiting its transcriptional repression capabilities. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Romidepsin is another histone deacetylase inhibitor that could impede ZMYM6NB's chromatin modulation functions by altering histone acetylation, potentially inhibiting its gene silencing effects. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $156.00 $572.00 | ||
Belinostat is a histone deacetylase inhibitor that can hyperacetylate histones, potentially preventing ZMYM6NB from binding to chromatin and inhibiting its associated gene repression activities. | ||||||
JNJ-26481585 | 875320-29-9 | sc-364515 sc-364515A | 5 mg 50 mg | $321.00 $1224.00 | ||
Quisinostat is a broad-spectrum histone deacetylase inhibitor that could affect ZMYM6NB by maintaining an acetylated state of histones, which may interfere with ZMYM6NB's role in chromatin structure and function. | ||||||
CI 994 | 112522-64-2 | sc-205245 sc-205245A | 10 mg 50 mg | $99.00 $536.00 | 1 | |
Tacedinaline inhibits histone deacetylases, which could lead to a disruption of ZMYM6NB's interaction with chromatin due to an altered acetylation landscape, potentially inhibiting its function in transcriptional repression. | ||||||
Chidamide | 743420-02-2 | sc-364462 sc-364462A sc-364462B | 1 mg 5 mg 25 mg | $62.00 $250.00 $1196.00 | ||
Chidamide is a histone deacetylase inhibitor that can potentially affect ZMYM6NB by changing the acetylation status of histones, which might disrupt ZMYM6NB's chromatin interactions and inhibit its function. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid is a histone deacetylase inhibitor that could affect ZMYM6NB by increasing histone acetylation levels, potentially hindering ZMYM6NB's capacity for chromatin modification and gene silencing. | ||||||